CVE-2026-102917

CVE-2026-102917 is a high-severity vulnerability in Ibm I with a CVSS 3.x base score of 7.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-269.

Key facts

Description

IBM i 7.3, 7.4, 7.5, and 7.6 is vulnerable to an authenticated attacker elevating their privilege. A bad actor could exploit this vulnerability to perform operations with QSECOFR/Root authority on the system.

Frequently asked questions

What is CVE-2026-102917?
IBM i 7.3, 7.4, 7.5, and 7.6 is vulnerable to an authenticated attacker elevating their privilege. A bad actor could exploit this vulnerability to perform operations with QSECOFR/Root authority on the system.
How severe is CVE-2026-102917?
CVE-2026-102917 has a CVSS 3.x base score of 7.8, rated high severity. It is exploitable over local access with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2026-102917 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (3rd percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2026-102917?
CVE-2026-102917 primarily affects Ibm I. In total, 4 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2026-102917?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2026-102917 published?
CVE-2026-102917 was published on 2026-10-16 and last updated on 2026-10-23.

References

Affected products (4)

More vulnerabilities in Ibm I

All CVEs affecting Ibm I →

Other CWE-269 (Improper Privilege Management) vulnerabilities

Browse all CWE-269 (Improper Privilege Management) vulnerabilities →